Besides the repeated high predictive accuracy for both overall and early-stage NPC diagnosis using the full-marker panel, two parsimonious panels (one involving four EBV IgA and IgG markers and another with only two IgG markers) were further identified, which showed 99.2% and 98.4% accuracy in detecting clinically diagnosed NPC, respectively.23 Here, CD79A is linked to nasopharyngeal carcinoma.